Perimeter Medical Imaging, Inc. (“Perimeter Medical”) announced today that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the second generation of their platform imaging tool used in the evaluation of human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization.
Read MorePR Newswire/New World Resource Corp. and Perimeter Medical Imaging, Inc. announced today that they entered into a non-binding letter of intent for the acquisition of all of the issued and outstanding shares of Perimeter Medical by New World in a reverse takeover transaction.
Read MoreWe are expanding and moving our location to accommodate our growth.
Read MorePerimeter Medical Imaging Inc., a developer of real time imaging systems for in-surgery tissue assessment, is pleased to announce that Suzanne Foster, former General Manager of Medtronic Transformative Solutions, will be joining Perimeter’s Board of Directors.
Read MoreGoing to RSNA 2017 this year? We will be presenting our latest technology and imaging correlations at RSNA 2017.
Read MorePerimeter Medical Imaging Inc., a developer of real time imaging systems for in-surgery tissue assessment, is pleased to announce that Dr. Franklyn Prendergast, will be joining Perimeter’s Board of Directors.
Read MoreWe’re delighted to be among more than 75 exhibitors at the American Society of Breast Surgery Conference April 27-30 at the Bellagio Las Vegas.
Read MorePerimeter Medical Imaging, Inc., a developer of real time optical imaging systems for intraoperative tissue assessment, today announced that its President and Chief Executive Officer will present at the sixth annual Healthcare Investor Conference [...]
Read MorePerimeter Medical Imaging, Inc., a developer of real time optical imaging systems for intraoperative tissue assessment, was invited to speak at CAP16.
Read MoreWilfrid Laurier University’s Lazaridis School of Business & Economics will recognize 11 graduates for their outstanding achievements at the fourth annual Lazaridis School Alumni Awards Sept. 23.
Read MoreLast week at RESI on MaRS, the MaRS HealthKick Innovation Challenge showcased 30 companies from the digital health, biotech, medical device and diagnostics sectors.
Read MorePerimeter Medical Imaging, Inc., an innovative medical imaging company whose mission is to revolutionize tissue removal surgery for surgeons and patients, today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its OTIS™ 1.0 Optical Coherence Tomography System.
Read MorePerimeter Medical Imaging, Inc., a developer of real time imaging systems for in-surgery tissue assessment, today presented an invited technical talk on the "Development and clinical translation of OTIS: a wide-field OCT imaging device for ex-vivo tissue characterization".
Read MorePerimeter Medical Imaging, Inc., a developer of real time imaging systems for in-surgery tumour margin assessment, today announced they have reached a data sharing agreement with Columbia University whereby the company and University will share Optical Coherence Tomography (OCT) image data to accelerate research efforts for high resolution tissue imaging.
Read MorePerimeter Medical Imaging, Inc., a developer of real time imaging systems for in-surgery tissue assessment, is pleased to announce the closing of their $5 million Series A financing.
Read MorePerimeter Medical Imaging, Inc., a developer of real time imaging systems for in-surgery tumour margin assessment, today announced it is receiving up to $980,000 from the Government of Canada through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario).
Read MorePerimeter Medical Imaging Inc., a developer of real time imaging systems for in-surgery tumor margin assessment, today named Doug Janzen as Chairman of the Board.
Read MorePerimeter Medical Imaging Inc., a developer of real time imaging systems for in surgery tumour margin assessment, today announced financing support for the next phase of product and clinical development, provided by the Health Technology Commercialization Program through htx.ca - The Health Technology Exchange (HTX) and with the support of Princess Margaret Cancer Centre, a University Health Network hospital.
Read More